Effects of LAMC1 gene silencing on proliferation and cell cycle of bladder cancer cells
LI Binqi1 LI Wenming2▲
1.Department of General, Handan Central Hospital, Hebei Province, Handan 056001, China; 2.Pre-hospital Emergency Aid, Handan Central Hospital, Hebei Province, Handan 056001, China
Abstract：Objective To investigate the expression of recombinant laminin gamma 1 (LAMC1) in bladder cancer cells and the effect of silencing lamc1 gene expression on the proliferation and cell cycle of bladder cancer cells. Methods Cancer and adjacent tissues of 48 patients with bladder cancer admitted to Handan Central Hospital, Hebei Province from January 2019 to December 2021 were selected. RT-qPCR was used to detect the expression of LAMC1 mRNA in UMUC3, T24, 5637, and J82 cells. LAMC1-siRNA plasmid was transfected into 5637 cells, LAMC1 silencing group and negative control group were set up, and the transfection efficiency was verified by RT-qPCR and Western blot. CCK-8 assay, clonogenesis assay and flow cytometry were used to detect the effect of LAMC1 gene silencing on the proliferation, clonogenesis ability, and cell cycle of bladder cancer cells. Western blot was used to detect the expression levels of cyclin A, cyclin D1, p16, and p21. Results The expression level of LAMC1 mRNA in 5637 cells was higher than that in UMUC3, T24, and J82 cells (P＜0.05). There was no significant difference in LAMC1 positive expression rate between bladder and paracancer tissues (P＞0.05). LAMC1 mRNA and protein expression levels in LAMC1 silencing group were lower than those in negative control group (P＜0.01). Cell proliferation and clonogenesis in LAMC1 silencing group were lower than those in negative control group (P＜0.01). The percentage of S phase cells in LAMC1 silencing group was higher than that in negative control group (P＜0.01), and the percentage of G1 phase cells was higher than that in negative control group (P＜0.01). The expression levels of cyclin D1 and cyclin A proteins in LAMC1 silencing group were highly lower than those in negative control group (P＜0.01), while the expression levels of p16 and p21 proteins were higher than those in negative control group (P＜0.01). Conclusion Silencing LAMC1 gene expression can inhibit the expression of cell cycle related proteins, thus inhibiting the proliferation of bladder cancer 5637 cells, suggesting that LAMC1 may be a potential therapeutic target for bladder cancer.
李彬琦1 李文明2▲. 层粘连蛋白γ1基因沉默对膀胱癌细胞增殖及细胞周期的影响[J]. 中国医药导报, 2023, 20(30): 18-23.
LI Binqi1 LI Wenming2▲. Effects of LAMC1 gene silencing on proliferation and cell cycle of bladder cancer cells. 中国医药导报, 2023, 20(30): 18-23.
[1] Sung H，Ferlay J，Siegel RL，et al. Global Cancer Statistics 2020：GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin，2021，71（3）：209-249. [2] Lobo N，Afferi L，Moschini M，et al. Epidemiology，Screening，and Prevention of Bladder Cancer [J]. Eur Urol Oncol，2022， 5（6）：628-639. [3] Compérat E，Amin MB，Cathomas R，et al. Current best practice for bladder cancer：a narrative review of diagnostics and treatments [J]. Lancet，2022，400（10364）：1712-1721. [4] Morton G. Bladder Cancer：New Insights Into Dose，Volume and Prognostic Biomarkers[J]. Clin Oncol （R Coll Radiol），2022，34（10）：622-624. [5] Song Q，Zhou R，Shu F，et al. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer [J]. Front Immunol，2022，13：958368. [6] Miyamoto DT，Mouw KW，Feng FY，et al. Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer [J]. Lancet Oncol，2018，19（12）：683-695. [7] Martinez Rodriguez RH，Buisan Rueda O，Ibarz L. Bladder cancer：Present and future[J]. Med Clin （Barc），2017，149（10）：449-455. [8] Mohanty SK，Lobo A，Mishra SK，et al. Precision Medicine in Bladder Cancer：Present Challenges and Future Directions [J]. J Pers Med，2023，13（5）：756. [9] Solimani F，Pollmann R，Ishii N，et al. Diagnosis of anti- laminin γ-1 pemphigoid by immunoblot analysis [J]. J Eur Acad Dermatol Venereol，2019，33（4）：735-741. [10] Patel TR，Morris GA，Zwolanek D，et al. Nano-structure of the laminin γ-1 short arm reveals an extended and curved mu- ltidomain assembly [J]. Matrix Biol，2010，29（7）：565-572. [11] Simon-Assmann P. The laminin family：founding members of the basement membrane [J]. Cell Adh Migr，2013，7（1）：44-47. [12] Lou J，Gong J，Ke J，et al. A functional polymorphism located at transcription factor binding sites，rs6695837 near LAMC1 gene，confers risk of colorectal cancer in Chinese populations [J]. Carcinogenesis，2017，38（2）：177-183. [13] Mou Y，Sun Q. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 （laminin subunit gamma 1） [J]. Bioengineered，2022，13（1）：746-758. [14] Yamaguchi M，Ebihara N，Shima N，et al. Adhesion，migr- ation，and proliferation of cultured human corneal endo- thelial cells by laminin-5 [J]. Invest Ophthalmol Vis Sci，2011，52（2）：679-684. [15] Zhou J，Zhang Y，Han Z，et al. miR-506 contributes to ma- lignancy of cutaneous squamous cell carcinoma via targeting of P65 and LAMC1 [J]. Cell Cycle，2019，18（3）：333-345. [16] Kashima H，Wu RC，Wang Y，et al. Laminin C1 expression by uterine carcinoma cells is associated with tumor progres- sion [J]. Gynecol Oncol，2015，139（2）：338-344. [17] Ke HL，Ke RH，Li B，et al. Association between laminin γ1 expression and meningioma grade，recurrence，and progre- ssionfree survival [J]. Acta Neurochir （Wien），2013，155（1）：165-171. [18] Kinoshita T，Nohata N，Hanazawa T，et al. Tumour-suppr- essive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma [J]. Br J Cancer，2013， 109（10）：2636-2645. [19] Nishikawa R，Goto Y，Kojima S，et al. Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer [J]. Int J Oncol，2014，45（1）：401-410. [20] Zhang Y，Xi S，Chen J，et al. Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma [J]. J Cancer，2017，8（15）：2992-3000. [21] Yang ZP，Ma HS，Wang SS，et al. LAMC1 mRNA promotes malignancy of hepatocellular carcinoma cells by competing for MicroRNA-124 binding with CD151 [J]. IUBMB Life，2017，69（8）：595-605. [22] Mladenov E，Magin S，Soni A，et al. DNA double-strand- break repair in higher eukaryotes and its role in genomic instability and cancer：Cell cycle and proliferation-dep- endent regulation [J]. Semin Cancer Biol，2016，37/38：51-64. [23] Roy D，Sheng GY，Herve S，et al. Interplay between cancer cell cycle and metabolism：Challenges，targets and therap- eutic opportunities [J]. Biomed Pharmacother，2017，89：288-296. [24] Kaluzki I，Hailemariam-Jahn T，Doll M，et al. Dimethylfu- marate Inhibits Colorectal Carcinoma Cell Proliferation：Evidence for Cell Cycle Arrest，Apoptosis and Autophagy [J]. Cells，2019，8（11）：1329. [25] Hoffman RM，Yano S. Tumor-Specific S/G2-Phase Cell Cycle Arrest of Cancer Cells by Methionine Restriction [J]. Methods Mol Biol，2019，1866：49-60.
2023, Vol. 20 
京公网安备 11010502046598号